Utilization Patterns of Single-Fraction and Short- Course Radiotherapeutic Schedules in the Management of Bone Metastases

被引:1
|
作者
Koduri, Sravya [1 ]
Abel, Stephen [2 ]
Bergin, John [2 ]
Fuhrer, Russell [2 ]
Beriwal, Sushil [2 ]
Wegner, Rodney E. [2 ]
机构
[1] Lankenau Med Ctr, Dept Med, Philadelphia, PA USA
[2] Allegheny Hlth Network Canc Inst, Div Radiat Oncol, Pittsburgh, PA 15224 USA
关键词
D O I
10.1016/j.adro.2023.101176
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Bone metastases are common, occurring in 60% to 70% of patients with advanced malignancies. Historically, bone-directed radiation therapy regimens of 30 Gy over 10 fractions were used. However, prospective randomized data suggest equivalent pain relief with shorter-course regimens. The American Society for Radiation Oncology Choosing Wisely Campaign encourages clinicians to consider shorter-course palliative regimens in patients with limited prognosis. A retrospective analysis was performed to assess patterns of short-course and single-fraction radiation therapy during the past 5 years.Methods and Materials: We queried our electronic medical record (MOSAIQ) from 2016 to 2020 for patients with bone metastases who received palliative radiation therapy. Patients receiving >10 fractions or Medicare-approved palliative courses of radiation (30 Gy/10 fractions, 24 Gy/6 fractions, 20 Gy/5 fractions, 8 Gy/1 fraction) were included. Treatment department was defined as academic (n = 2) versus community (n = 12). Short-course treatment was defined as <6 fractions, whereas long-course included patients receiving >10 fractions. Patients were subdivided based on age and disease site. Physicians were grouped according to their year of residency completion. Multivariable logistic regression analysis identified predictors of short-course and single-fraction treatment.Results: We identified 1004 patients with 1768 bony metastases meeting inclusion criteria. The spine was the most common site, followed by pelvis/hip, extremity, and other site. Use of short-course treatment increased from 40% in 2016 to 50% in 2020. Single-fraction treatment increased from 7% in 2016 to 11% in 2020. Predictors of shorter courses included treatment at academic centers, more recent treatment, patient age >76 years, and nonspine anatomic site. Predictors of single-fraction treatment included treatment at academic centers, treating physician residency completion after 2010, patient age >76 years, and treatment to extremity or other site.Conclusions: Rates of short-course and single-fraction bone-directed radiation therapy increased within our health system over time. Treatment receipt at academic centers was associated with both short-course and single-fraction regimens. Physicians completing residency after 2010 were more likely to deliver single-fraction therapy.(c) 2023 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:5
相关论文
共 48 条
  • [1] Utilization Patterns of Single Fraction and Short Course Radiotherapeutic Schedules in the Management of Bone Metastases
    Bergin, J.
    Abel, S.
    Fortunato, M.
    Fuhrer, R.
    Wegner, R. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E484 - E485
  • [2] Single-fraction radiotherapy for bone metastases
    Das, Manjulika
    LANCET ONCOLOGY, 2019, 20 (06): : E296 - E296
  • [3] Single-Fraction Radiation Treatment for Uncomplicated Bone Metastases #335
    Rich, Shayna E.
    Johnstone, Candice
    JOURNAL OF PALLIATIVE MEDICINE, 2017, 20 (09) : 1032 - 1033
  • [4] Single-Fraction Radiotherapy (SFRT) For Bone Metastases: Patient Selection And Perspectives
    Loi, Mauro
    Nuyttens, Joost J.
    Desideri, Isacco
    Greto, Daniela
    Livi, Lorenzo
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 9397 - 9408
  • [5] Adoption of single-fraction radiotherapy for uncomplicated bone metastases in a tertiary centre
    Peters, C.
    Vandewiele, J.
    Lievens, Y.
    Van Eijkeren, M.
    Fonteyne, V.
    Boterberg, T.
    Deseyne, P.
    Veldeman, L.
    De Neve, W.
    Monten, C.
    Braems, S.
    Duprez, F.
    Vandecasteele, K.
    Ost, P.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S663 - S663
  • [6] Single-fraction radiation retreatment for bone metastases: role of a rapid access clinic
    Kim, Minsoo
    Maldonado, Jose Alberto
    Pandey, Prasamsa
    El Alam, Molly B.
    Kouzy, Ramez
    Christopherson, Kaitlin
    Minsky, Bruce D.
    Quynh-Nhu Nugyen
    Grosshans, David
    Lin, Lilie L.
    Mitchell, Melissa P.
    Klopp, Ann H.
    Lee, Percy P.
    Bird, Justin
    Satcher, Robert
    Lewis, Valerae O.
    Lin, Patrick P.
    Tang, Chad
    Koong, Albert C.
    Moon, Bryan
    Colbert, Lauren E.
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2024, 14 (E2) : E2087 - E2093
  • [7] Single-fraction 8Gy radiotherapy for bone metastases of lung cancer
    Golubicic, I.
    Jovanovic, N.
    Isakovic, S.
    Borojevic, N.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S432 - S432
  • [8] Factors Affecting the Use of Single-Fraction Radiotherapy for the Palliation of Bone Metastases in Australia
    Petrushevski, A. N.
    Gabriel, G. S.
    Hanna, T. P.
    Allen, S.
    Allison, R. W.
    Barton, M. B.
    CLINICAL ONCOLOGY, 2015, 27 (04) : 205 - 212
  • [9] Prospective study on the feasibility of single-fraction SABR for bone and lymph node metastases
    Mercier, C.
    Claessens, M.
    De Kerf, G.
    Billiet, C.
    Joye, I.
    Verellen, D.
    Ost, P.
    Dirix, P.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1593 - S1594
  • [10] Debate: Single-fraction treatment should be standard in the retreatment of uncomplicated bone metastases
    Tsang, Derek S.
    Yau, Vivian
    Raziee, Hamid
    Niglas, Mark
    Soliman, Hany
    Chow, Edward
    Tsao, May
    ANNALS OF PALLIATIVE MEDICINE, 2015, 4 (04) : 207 - 213